Closed-loop artificial pancreas systems: Engineering the algorithms. Diabetes care 2014;37:1191-1197

Diabetes Care

Volumn 37, Issue 10, 2014, Pages e228-

  Doyle, Francis J ^a,b   Huyett, Lauren M ^a,b   Lee, Joon Bok ^a,b   Zisser, Howard C ^a,b   Kerr, David ^b   Dassau, Eyal ^a,b  

^a University of California   (United States)

^b SANSUM DIABETES RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL PANCREAS; BIOENGINEERING; CLINICAL EFFECTIVENESS; GLYCEMIC CONTROL; HUMAN; NOTE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT DECISION MAKING; PERSONAL EXPERIENCE; ALGORITHM; BIOMEDICAL ENGINEERING; DIABETES MELLITUS, TYPE 1; TRENDS;

ALGORITHMS; BIOMEDICAL ENGINEERING; DIABETES MELLITUS, TYPE 1; HUMANS; PANCREAS, ARTIFICIAL;

EID: 84908219151     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-1693     Document Type: Note

References (5)

1. Oliver NS, Evans ML, Hovorka R, et al. Comment on Doyle et al. Closed-loop artificial pancreas systems: engineering the algorithms. Diabetes Care 2014;37:1191-1197 (Letter).
2. Diabetes Care 2014;37:e226-e227. DOI: 10.2337/dc14-1499.
3. Doyle FJ III, Huyett LM, Lee JB, Zisser HC, Dassau E. Closed-loop artificial pancreas systems: engineering the algorithms. Diabetes Care 2014;37:1191-1197.
4. Patients Call for Innovation! Diabetes Mine Summit 2012 [article online], 2012. Available from http://www.diabetesmine.com/2012/11/patients-call-for-innovation-diabetesminesummit-2012.html. Accessed 10 July 2014.
5. Bevier WC, Fuller SM, Fuller RP, et al. Artificial pancreas (AP) clinical trial participants' acceptance of future AP technology. Diabetes Technol Ther. 8 May 2014 [Epub ahead of print].